Kidney Disease Medical Group

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease3 trials
• IgA nephropathy2 trials
• Coronary artery disease1 trial
• Peripheral artery disease1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Bayer1 trial
• CSL Behring1 trial

Running trials

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

  Contact: Trial Registration Coordinator

• Active, not recruiting

  A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

  NCT05348733· Bayer· Source

• Active, not recruiting

  Atrasentan in Patients With Proteinuric Glomerular Diseases

  NCT04573920· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Atrasentan in Patients With IgA Nephropathy

  NCT04573478· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Peripheral artery disease1 recruiting